Global Non-invasive Prenatal Genetic Testing Market Growth (Status and Outlook) 2022-2028
The global market for Non-invasive Prenatal Genetic Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Non-invasive Prenatal Genetic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Non-invasive Prenatal Genetic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Non-invasive Prenatal Genetic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Non-invasive Prenatal Genetic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Non-invasive Prenatal Genetic Testing players cover Labcorp, Illumina, Roche, Natera and Premaitha Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Non-invasive Prenatal Genetic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Non-invasive Prenatal Genetic Testing market, with both quantitative and qualitative data, to help readers understand how the Non-invasive Prenatal Genetic Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Non-invasive Prenatal Genetic Testing market and forecasts the market size by Type (NIPT Basic Edition and NIPT Plus,), by Application (Elderly Primipara, Assisted Reproductive Population and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
NIPT Basic Edition
NIPT Plus
Segmentation by application
Elderly Primipara
Assisted Reproductive Population
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Labcorp
Illumina
Roche
Natera
Premaitha Health
The Beijing Genomics Institute
Berry Genomics
Daan Gene
Annoroad
CapitalBio Technology
Chapter Introduction
Chapter 1: Scope of Non-invasive Prenatal Genetic Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Non-invasive Prenatal Genetic Testing market size and CAGR, Non-invasive Prenatal Genetic Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Non-invasive Prenatal Genetic Testing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Non-invasive Prenatal Genetic Testing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Non-invasive Prenatal Genetic Testing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Labcorp, Illumina, Roche, Natera, Premaitha Health, The Beijing Genomics Institute, Berry Genomics, Daan Gene and Annoroad, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-invasive Prenatal Genetic Testing Market Size 2017-2028
2.1.2 Non-invasive Prenatal Genetic Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Non-invasive Prenatal Genetic Testing Segment by Type
2.2.1 NIPT Basic Edition
2.2.2 NIPT Plus
2.3 Non-invasive Prenatal Genetic Testing Market Size by Type
2.3.1 Non-invasive Prenatal Genetic Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Non-invasive Prenatal Genetic Testing Market Size Market Share by Type (2017-2022)
2.4 Non-invasive Prenatal Genetic Testing Segment by Application
2.4.1 Elderly Primipara
2.4.2 Assisted Reproductive Population
2.4.3 Others
2.5 Non-invasive Prenatal Genetic Testing Market Size by Application
2.5.1 Non-invasive Prenatal Genetic Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Non-invasive Prenatal Genetic Testing Market Size Market Share by Application (2017-2022)
3 Non-invasive Prenatal Genetic Testing Market Size by Player
3.1 Non-invasive Prenatal Genetic Testing Market Size Market Share by Players
3.1.1 Global Non-invasive Prenatal Genetic Testing Revenue by Players (2020-2022)
3.1.2 Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Players (2020-2022)
3.2 Global Non-invasive Prenatal Genetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Non-invasive Prenatal Genetic Testing by Regions
4.1 Non-invasive Prenatal Genetic Testing Market Size by Regions (2017-2022)
4.2 Americas Non-invasive Prenatal Genetic Testing Market Size Growth (2017-2022)
4.3 APAC Non-invasive Prenatal Genetic Testing Market Size Growth (2017-2022)
4.4 Europe Non-invasive Prenatal Genetic Testing Market Size Growth (2017-2022)
4.5 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size Growth (2017-2022)
5 Americas
5.1 Americas Non-invasive Prenatal Genetic Testing Market Size by Country (2017-2022)
5.2 Americas Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022)
5.3 Americas Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Prenatal Genetic Testing Market Size by Region (2017-2022)
6.2 APAC Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022)
6.3 APAC Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Non-invasive Prenatal Genetic Testing by Country (2017-2022)
7.2 Europe Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022)
7.3 Europe Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-invasive Prenatal Genetic Testing by Region (2017-2022)
8.2 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022)
8.3 Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Non-invasive Prenatal Genetic Testing Market Forecast
10.1 Global Non-invasive Prenatal Genetic Testing Forecast by Regions (2023-2028)
10.1.1 Global Non-invasive Prenatal Genetic Testing Forecast by Regions (2023-2028)
10.1.2 Americas Non-invasive Prenatal Genetic Testing Forecast
10.1.3 APAC Non-invasive Prenatal Genetic Testing Forecast
10.1.4 Europe Non-invasive Prenatal Genetic Testing Forecast
10.1.5 Middle East & Africa Non-invasive Prenatal Genetic Testing Forecast
10.2 Americas Non-invasive Prenatal Genetic Testing Forecast by Country (2023-2028)
10.2.1 United States Non-invasive Prenatal Genetic Testing Market Forecast
10.2.2 Canada Non-invasive Prenatal Genetic Testing Market Forecast
10.2.3 Mexico Non-invasive Prenatal Genetic Testing Market Forecast
10.2.4 Brazil Non-invasive Prenatal Genetic Testing Market Forecast
10.3 APAC Non-invasive Prenatal Genetic Testing Forecast by Region (2023-2028)
10.3.1 China Non-invasive Prenatal Genetic Testing Market Forecast
10.3.2 Japan Non-invasive Prenatal Genetic Testing Market Forecast
10.3.3 Korea Non-invasive Prenatal Genetic Testing Market Forecast
10.3.4 Southeast Asia Non-invasive Prenatal Genetic Testing Market Forecast
10.3.5 India Non-invasive Prenatal Genetic Testing Market Forecast
10.3.6 Australia Non-invasive Prenatal Genetic Testing Market Forecast
10.4 Europe Non-invasive Prenatal Genetic Testing Forecast by Country (2023-2028)
10.4.1 Germany Non-invasive Prenatal Genetic Testing Market Forecast
10.4.2 France Non-invasive Prenatal Genetic Testing Market Forecast
10.4.3 UK Non-invasive Prenatal Genetic Testing Market Forecast
10.4.4 Italy Non-invasive Prenatal Genetic Testing Market Forecast
10.4.5 Russia Non-invasive Prenatal Genetic Testing Market Forecast
10.5 Middle East & Africa Non-invasive Prenatal Genetic Testing Forecast by Region (2023-2028)
10.5.1 Egypt Non-invasive Prenatal Genetic Testing Market Forecast
10.5.2 South Africa Non-invasive Prenatal Genetic Testing Market Forecast
10.5.3 Israel Non-invasive Prenatal Genetic Testing Market Forecast
10.5.4 Turkey Non-invasive Prenatal Genetic Testing Market Forecast
10.5.5 GCC Countries Non-invasive Prenatal Genetic Testing Market Forecast
10.6 Global Non-invasive Prenatal Genetic Testing Forecast by Type (2023-2028)
10.7 Global Non-invasive Prenatal Genetic Testing Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Labcorp
11.1.1 Labcorp Company Information
11.1.2 Labcorp Non-invasive Prenatal Genetic Testing Product Offered
11.1.3 Labcorp Non-invasive Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Labcorp Main Business Overview
11.1.5 Labcorp Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Non-invasive Prenatal Genetic Testing Product Offered
11.2.3 Illumina Non-invasive Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Non-invasive Prenatal Genetic Testing Product Offered
11.3.3 Roche Non-invasive Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 Natera
11.4.1 Natera Company Information
11.4.2 Natera Non-invasive Prenatal Genetic Testing Product Offered
11.4.3 Natera Non-invasive Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Natera Main Business Overview
11.4.5 Natera Latest Developments
11.5 Premaitha Health
11.5.1 Premaitha Health Company Information
11.5.2 Premaitha Health Non-invasive Prenatal Genetic Testing Product Offered
11.5.3 Premaitha Health Non-invasive Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Premaitha Health Main Business Overview
11.5.5 Premaitha Health Latest Developments
11.6 The Beijing Genomics Institute
11.6.1 The Beijing Genomics Institute Company Information
11.6.2 The Beijing Genomics Institute Non-invasive Prenatal Genetic Testing Product Offered
11.6.3 The Beijing Genomics Institute Non-invasive Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 The Beijing Genomics Institute Main Business Overview
11.6.5 The Beijing Genomics Institute Latest Developments
11.7 Berry Genomics
11.7.1 Berry Genomics Company Information
11.7.2 Berry Genomics Non-invasive Prenatal Genetic Testing Product Offered
11.7.3 Berry Genomics Non-invasive Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Berry Genomics Main Business Overview
11.7.5 Berry Genomics Latest Developments
11.8 Daan Gene
11.8.1 Daan Gene Company Information
11.8.2 Daan Gene Non-invasive Prenatal Genetic Testing Product Offered
11.8.3 Daan Gene Non-invasive Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Daan Gene Main Business Overview
11.8.5 Daan Gene Latest Developments
11.9 Annoroad
11.9.1 Annoroad Company Information
11.9.2 Annoroad Non-invasive Prenatal Genetic Testing Product Offered
11.9.3 Annoroad Non-invasive Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Annoroad Main Business Overview
11.9.5 Annoroad Latest Developments
11.10 CapitalBio Technology
11.10.1 CapitalBio Technology Company Information
11.10.2 CapitalBio Technology Non-invasive Prenatal Genetic Testing Product Offered
11.10.3 CapitalBio Technology Non-invasive Prenatal Genetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 CapitalBio Technology Main Business Overview
11.10.5 CapitalBio Technology Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Non-invasive Prenatal Genetic Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of NIPT Basic Edition
Table 3. Major Players of NIPT Plus
Table 4. Non-invasive Prenatal Genetic Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Non-invasive Prenatal Genetic Testing Market Size Market Share by Type (2017-2022)
Table 7. Non-invasive Prenatal Genetic Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Non-invasive Prenatal Genetic Testing Market Size Market Share by Application (2017-2022)
Table 10. Global Non-invasive Prenatal Genetic Testing Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Player (2020-2022)
Table 12. Non-invasive Prenatal Genetic Testing Key Players Head office and Products Offered
Table 13. Non-invasive Prenatal Genetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Non-invasive Prenatal Genetic Testing Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Non-invasive Prenatal Genetic Testing Market Size Market Share by Regions (2017-2022)
Table 18. Americas Non-invasive Prenatal Genetic Testing Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Non-invasive Prenatal Genetic Testing Market Size Market Share by Country (2017-2022)
Table 20. Americas Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Non-invasive Prenatal Genetic Testing Market Size Market Share by Type (2017-2022)
Table 22. Americas Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Non-invasive Prenatal Genetic Testing Market Size Market Share by Application (2017-2022)
Table 24. APAC Non-invasive Prenatal Genetic Testing Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Non-invasive Prenatal Genetic Testing Market Size Market Share by Region (2017-2022)
Table 26. APAC Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Non-invasive Prenatal Genetic Testing Market Size Market Share by Type (2017-2022)
Table 28. APAC Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Non-invasive Prenatal Genetic Testing Market Size Market Share by Application (2017-2022)
Table 30. Europe Non-invasive Prenatal Genetic Testing Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Non-invasive Prenatal Genetic Testing Market Size Market Share by Country (2017-2022)
Table 32. Europe Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Non-invasive Prenatal Genetic Testing Market Size Market Share by Type (2017-2022)
Table 34. Europe Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Non-invasive Prenatal Genetic Testing Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Non-invasive Prenatal Genetic Testing
Table 43. Key Market Challenges & Risks of Non-invasive Prenatal Genetic Testing
Table 44. Key Industry Trends of Non-invasive Prenatal Genetic Testing
Table 45. Global Non-invasive Prenatal Genetic Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Non-invasive Prenatal Genetic Testing Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Non-invasive Prenatal Genetic Testing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Non-invasive Prenatal Genetic Testing Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Non-invasive Prenatal Genetic Testing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Non-invasive Prenatal Genetic Testing Market Size Market Share Forecast by Application (2023-2028)
Table 51. Labcorp Details, Company Type, Non-invasive Prenatal Genetic Testing Area Served and Its Competitors
Table 52. Labcorp Non-invasive Prenatal Genetic Testing Product Offered
Table 53. Labcorp Non-invasive Prenatal Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Labcorp Main Business
Table 55. Labcorp Latest Developments
Table 56. Illumina Details, Company Type, Non-invasive Prenatal Genetic Testing Area Served and Its Competitors
Table 57. Illumina Non-invasive Prenatal Genetic Testing Product Offered
Table 58. Illumina Main Business
Table 59. Illumina Non-invasive Prenatal Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Illumina Latest Developments
Table 61. Roche Details, Company Type, Non-invasive Prenatal Genetic Testing Area Served and Its Competitors
Table 62. Roche Non-invasive Prenatal Genetic Testing Product Offered
Table 63. Roche Main Business
Table 64. Roche Non-invasive Prenatal Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Roche Latest Developments
Table 66. Natera Details, Company Type, Non-invasive Prenatal Genetic Testing Area Served and Its Competitors
Table 67. Natera Non-invasive Prenatal Genetic Testing Product Offered
Table 68. Natera Main Business
Table 69. Natera Non-invasive Prenatal Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Natera Latest Developments
Table 71. Premaitha Health Details, Company Type, Non-invasive Prenatal Genetic Testing Area Served and Its Competitors
Table 72. Premaitha Health Non-invasive Prenatal Genetic Testing Product Offered
Table 73. Premaitha Health Main Business
Table 74. Premaitha Health Non-invasive Prenatal Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Premaitha Health Latest Developments
Table 76. The Beijing Genomics Institute Details, Company Type, Non-invasive Prenatal Genetic Testing Area Served and Its Competitors
Table 77. The Beijing Genomics Institute Non-invasive Prenatal Genetic Testing Product Offered
Table 78. The Beijing Genomics Institute Main Business
Table 79. The Beijing Genomics Institute Non-invasive Prenatal Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. The Beijing Genomics Institute Latest Developments
Table 81. Berry Genomics Details, Company Type, Non-invasive Prenatal Genetic Testing Area Served and Its Competitors
Table 82. Berry Genomics Non-invasive Prenatal Genetic Testing Product Offered
Table 83. Berry Genomics Main Business
Table 84. Berry Genomics Non-invasive Prenatal Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Berry Genomics Latest Developments
Table 86. Daan Gene Details, Company Type, Non-invasive Prenatal Genetic Testing Area Served and Its Competitors
Table 87. Daan Gene Non-invasive Prenatal Genetic Testing Product Offered
Table 88. Daan Gene Main Business
Table 89. Daan Gene Non-invasive Prenatal Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Daan Gene Latest Developments
Table 91. Annoroad Details, Company Type, Non-invasive Prenatal Genetic Testing Area Served and Its Competitors
Table 92. Annoroad Non-invasive Prenatal Genetic Testing Product Offered
Table 93. Annoroad Main Business
Table 94. Annoroad Non-invasive Prenatal Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Annoroad Latest Developments
Table 96. CapitalBio Technology Details, Company Type, Non-invasive Prenatal Genetic Testing Area Served and Its Competitors
Table 97. CapitalBio Technology Non-invasive Prenatal Genetic Testing Product Offered
Table 98. CapitalBio Technology Main Business
Table 99. CapitalBio Technology Non-invasive Prenatal Genetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. CapitalBio Technology Latest Developments
List of Figures
List of Figures
Figure 1. Non-invasive Prenatal Genetic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-invasive Prenatal Genetic Testing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Non-invasive Prenatal Genetic Testing Market Size Market Share by Type in 2021
Figure 7. Non-invasive Prenatal Genetic Testing in Elderly Primipara
Figure 8. Global Non-invasive Prenatal Genetic Testing Market: Elderly Primipara (2017-2022) & ($ Millions)
Figure 9. Non-invasive Prenatal Genetic Testing in Assisted Reproductive Population
Figure 10. Global Non-invasive Prenatal Genetic Testing Market: Assisted Reproductive Population (2017-2022) & ($ Millions)
Figure 11. Non-invasive Prenatal Genetic Testing in Others
Figure 12. Global Non-invasive Prenatal Genetic Testing Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Non-invasive Prenatal Genetic Testing Market Size Market Share by Application in 2021
Figure 14. Global Non-invasive Prenatal Genetic Testing Revenue Market Share by Player in 2021
Figure 15. Global Non-invasive Prenatal Genetic Testing Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Non-invasive Prenatal Genetic Testing Market Size 2017-2022 ($ Millions)
Figure 17. APAC Non-invasive Prenatal Genetic Testing Market Size 2017-2022 ($ Millions)
Figure 18. Europe Non-invasive Prenatal Genetic Testing Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size 2017-2022 ($ Millions)
Figure 20. Americas Non-invasive Prenatal Genetic Testing Value Market Share by Country in 2021
Figure 21. Americas Non-invasive Prenatal Genetic Testing Consumption Market Share by Type in 2021
Figure 22. Americas Non-invasive Prenatal Genetic Testing Market Size Market Share by Application in 2021
Figure 23. United States Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Non-invasive Prenatal Genetic Testing Market Size Market Share by Region in 2021
Figure 28. APAC Non-invasive Prenatal Genetic Testing Market Size Market Share by Application in 2021
Figure 29. China Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Non-invasive Prenatal Genetic Testing Market Size Market Share by Country in 2021
Figure 36. Europe Non-invasive Prenatal Genetic Testing Market Size Market Share by Type in 2021
Figure 37. Europe Non-invasive Prenatal Genetic Testing Market Size Market Share by Application in 2021
Figure 38. Germany Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size Market Share by Application in 2021
Figure 46. Egypt Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Non-invasive Prenatal Genetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 52. APAC Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 53. Europe Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 55. United States Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 56. Canada Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 59. China Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 60. Japan Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 61. Korea Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 63. India Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 64. Australia Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 65. Germany Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 66. France Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 67. UK Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 68. Italy Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 69. Russia Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 70. Spain Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 73. Israel Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Non-invasive Prenatal Genetic Testing Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets